Asia’s markets are mixed this Christmas Eve - but beneath the calm, powerful themes are moving capital fast as investors weigh healthcare breakthroughs, defence spending, and surging commodities.

Novo Nordisk jumps as US regulators approve the first-ever GLP-1 weight-loss pill, reshaping the obesity drug market.

US defence stocks rally, with Huntington Ingalls riding expectations of higher military spending and domestic shipbuilding.

Huawei defies expectations, pushing into ultra-luxury electric vehicles and outselling traditional European carmakers in China.

Meanwhile, copper and platinum hit record highs, fuelled by supply constraints, electrification, AI demand and tariff stockpiling.

From Singapore stocks to luxury crab replacing caviar, this is Market View - hosted by Michelle Martin solo.

See omnystudio.com/listener for privacy information.